The role of histology on survival of triple negative breast cancer.

被引：1
|
作者：
Parise, Carol [1 ]
Caggiano, Vincent [1 ]
机构：
[1] Sutter Inst Med Res, Sacramento, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e12590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12590
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting the RXR pathway for the prevention of triple-negative breast cancer.
    Moyer, Cassandra
    Hill, Jamal
    Coleman, Darian
    Sei, Shizuko
    Mohammed, Altaf
    Sanders, Martin
    Brown, Powel
    Mazumdar, Abhijit
    [J]. CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [42] Patterns of mutation enrichment in metastatic triple-negative breast cancer.
    Saravia, Cesar H.
    Flores, Claudio J.
    Schwarz, Luis Jesus
    Bravo, Leny
    Zavaleta, Jenny
    Araujo, Jhajaira M.
    Neciosup, Silvia P.
    Pinto, Joseph A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Induction chemotherapy for patients with Locally advanced triple negative breast cancer.
    Ignatova, Ekaterina
    Frolova, Mona
    Stenina, Marina B.
    Petrovsky, Alexander
    Tjulandin, Sergei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Lymphatic and vascular invasion patterns in triple-negative breast cancer.
    Yaman, S.
    Gumuskaya, B.
    Ozkan, C.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Hashmi, Quratul Ain
    Abdullah, Famya
    Duraishi, Arif Moin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Chemotherapy-related outcomes in triple-negative breast cancer.
    Wellmann, Rebecca M.
    Ghafouri, Sanaz N.
    McAndrew, Nicholas Patrick
    Hurvitz, Sara A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Disruption of mitochondrial metabolism by ClpP activation in triple negative breast cancer.
    Fennell, Emily M.
    Aponte-Collazo, Lucas J.
    Rushing, Blake R.
    Li, Yuan-Yuan
    Pathmasiri, Wimal
    Wynn, Joshua D.
    Graves, Paul R.
    Holmuhamedov, Ekhson L.
    Herring, Laura E.
    Iwanowicz, Edwin J.
    Graves, Lee M.
    [J]. CANCER RESEARCH, 2021, 81 (13)
  • [48] Distinct immune microenvironments stratify triple-negative breast cancer.
    Gruosso, Tina
    Kumar, Venkata Satya
    Gigoux, Mathieu
    Saleh, Sadiq
    Bertos, Nicholas
    Omeroglu, Atilla
    Zuo, Dongmei
    Meterissian, Sarkis
    Haibe-Kains, Benjamin
    Park, Morag
    [J]. MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 17 - 17
  • [49] Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
    O'Shaughnessy, Joyce
    Osborne, Cynthia
    Pippen, John E.
    Yoffe, Mark
    Patt, Debra
    Rocha, Christine
    Koo, Ingrid Chou
    Sherman, Barry M.
    Bradley, Charles
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 205 - 214
  • [50] MYC as a therapeutic target for the treatment of triple-negative breast cancer.
    Foley, Sarah A.
    Casten, Alina
    Kavanagh, Emma
    Synnott, Naoise C.
    Crown, John
    Larsson, Lars-Gunnar
    Duffy, Michael J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345